Since RAGE plays a key role in the regulation of immune system responses, and inflammatory processes, as well as various types of cancers [32], it could mediate the cellular progress and binding and correlate with the pathways of Jak/STATs and NF-κB signaling, which are considered promising targets for the development of novel anti-inflammatory diseases [33,34]. This evidence concerns the gene NFKB1 and cancer.